pharmaceuticals

Good heart health

Thursday’s Top Biopharma Movers

Not that many biotech and pharma companies were on the move Thursday, just one day before the inauguration. However, a few of the smaller caps made splash, while broad markets ...
Read Full Story »
Jon's friends

Wednesday’s Top Biopharma Winners

The third week of the New Year is halfway over, and a few biopharma companies made massive runs on the day. The health care sector was in trouble over the ...
Read Full Story »
bigger fish

What Eli Lilly Gets With CoLucid Acquisition

Eli Lilly and Co. (NYSE: LLY) has announced it has reached an agreement to acquire CoLucid Pharmaceuticals Inc. (NASDAQ: CLCD) in an all-cash transaction for $46.50 per share, or about ...
Read Full Story »
Female patient on gurney

Tuesday’s Top Biopharma Movers

Some biotech and pharma companies were on the move Tuesday. A few of the smaller caps made tremendous gains on the day, as the fourth-quarter earnings season is kicking off. ...
Read Full Story »
Good heart health

Thursday’s Biggest Biopharma Winners

The health care sector was in trouble over the past year, coming under fire from congressional hearings and politicians on the campaign trail. At first 2017 seemed like it could ...
Read Full Story »
Medicine pills

Why 3 Analysts Upgraded Merck Simultaneously

It may seem hard to believe that a Big Pharma drug stock might be a favorite for the year ahead when the attacks against drug pricing and competition do not ...
Read Full Story »
Prescription drugs

Major Pharma Short Interest Declines Ahead of Trump Comments

The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
100 dollar bills

Wednesday’s Top Biopharma Movers

Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive ...
Read Full Story »
Valeant Pharmaceuticals

Why Valeant Is Making a Run

Valeant Pharmaceuticals International Inc. (NYSE: VRX) made waves early on Tuesday after the company offered a plethora of announcements. First the company gave an update on its late-stage psoriasis trial. ...
Read Full Story »
Doctor, Health (pulse) copy

Monday’s 4 Biggest Biopharma Movers

The second week of the New Year is now underway, and a few biotech companies made sizable runs to kick off the week. The health care sector was in trouble ...
Read Full Story »
hammered

4 Companies That Destroyed Shareholders Last Week

The S&P 500 and Dow Jones Industrial Average are pushing new highs as we close the first week of trading of 2017. Although the tailwind of the Trump rally has ...
Read Full Story »
Good heart health

Friday’s 6 Biopharma Movers That Can’t Be Ignored

There is a very positive sentiment in the health care sector considering the new Trump administration that will be taking over in just two weeks. The health care sector was ...
Read Full Story »
FDA_logo

6 Major FDA Decisions and Biopharma Catalysts Coming in January and February

Companies that reside within the biotech and pharmaceutical industries are subject to a sizable amount of risk in regards to their drug candidates passing clinical trials and gaining regulatory approval. ...
Read Full Story »
bigger fish

These 5 Biotech Stocks Could Be Big Takeover Targets in 2017

After a very tough year for the biotech stocks last year, they initially jumped after the election of Donald Trump as investors hoped that the rhetoric on drug pricing would ...
Read Full Story »
biotech word cloud

Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday

As the markets are continuing to heat up a few biotech and pharma companies made massive gains on Thursday. There is a very positive sentiment in the health care sector ...
Read Full Story »